A workshop on 'The Biology of Intracellular Bacterial Pathogens' was held last October in a venue of the International University of Andalusia (UNIA) located in the World Historic Heritage town of Baeza, in the South of Spain. This Workshop gathered leading scientists from around the world to discuss their latest findings related to the mechanisms that intracellular pathogens use to subvert and manipulate host cell functions. The workshop focused on novel aspects that imprint current research in this discipline, including the heterogeneous behaviour of the pathogen at the population level, the host determinants that modulate susceptibility to the infection, the search for new drugs to combat these particular types of infections and also cutting edge technologies based on new imaging approaches and the use of microfluidics. Discussion on these topics provided new insights into the biology of these pathogens and enriched the field with new ideas for understanding why colonization of the intracellular niche of eukaryotic cells is a preferred strategy used by important human pathogens.
Together with viruses, intracellular bacterial and parasite pathogens constitute the largest group of microorganisms inflicting human health. Bacteria that colonize the interior of the eukaryotic cell cause many important infectious diseases such as tuberculosis, typhoid fever, tularaemia, Q-fever, brucellosis and pneumonia among others, with high morbidity and mortality in humans. Noteworthy, many of these pathogens are also prone to establish asymptomatic infections. This duality is in most cases poorly understood at the molecular level. A feature frequently evidenced in infections caused by intracellular bacteria and parasites is the sophistication and variety of mechanisms directed to manipulate processes central to the host physiology, including cytoskeleton dynamics, vesicular trafficking, release of defence molecules and sensing of pathogen molecules. Despite abundant information, in most cases we cannot 'predict' the outcome of a given pathogen-host interplay. Many factors, including population diversity and bistability in the responses (from both the pathogen and the host) seem to play decisive roles in this delicate battle. With these ideas in mind, Jorge Galán (Yale University, New Haven) and Francisco García-del Portillo (Centro Nacional de Biotecnología-CSIC, Madrid) organized this Workshop, to which more than 50 participants attended.
Cell biology of intracellular infections: balanced coexistence of the two partners
The two first sessions of the Workshop were dedicated to discuss at the cellular level different aspects of the interaction occurring between intracellular bacteria and the host. Guy Tran Van Nhieu (CIRB, College de France, Paris) described how the human pathogen Shigella flexneri manipulates epithelial cell physiology at the site of bacterial entry. S. flexneri, which is devoid of classical adhesins or invasins at its surface, invades epithelial cells in two phases (Fig 1) . The first involves 'capture' of bacteria by nanometer thin micropodial extensions (NMEs) and retraction of the NME to bring bound bacteria in contact with the cell body. The second phase corresponds to the localized membrane ruffling linked to the activity of Shigella type three effectors. Local events spatially restricted to the site of bacterial entry include InsP3 signalling, Ca 2þ release from intracellular stores, and Erk1/2 activation in the infected cell, which promote 'NME retraction' and bacterial internalization. . This modulates the ability of these GTPases to conduct their normal cellular functions without preventing Rab1-mediated fusion of vesicles with the Legionellacontaining vacuole. Thus, precise manipulation of host GTPases by Legionella is a strategy used to convert an endocytic vacuole into a specialized compartment that supports bacterial replication. Thomas F. Meyer (Max Planck Institute for Infection Biology, Berlin) showed recent data obtained upon sRNAi-based screenings designed to unravel host functions that are targeted by a pathogen, during infection. This work has been performed with two relevant human pathogens, influenza A virus (IAV) and Chlamydia trachomatis. Meyer's group discovered that 300 human cellular factors could support or antagonize IAV replication. In the case of C. trachomatis, host functions related to inflammation, cytoskeletal dynamics, fatty acid/lipid metabolism, and DNA damage response, were shown to be involved in the infection. Importantly, these studies reveal that a 'host-directed therapy' may be an alternative and effective strategy to combat intracellular infections, minimizing the emergence of microbial resistance. Francisco García-del Portillo (Centro Nacional de Biotecnología-CSIC, Madrid) reported data on how Salmonella controls intracellular proliferation within fibroblasts, a cell type in which this pathogen establishes a persistence state. Data obtained in nongrowing intracellular bacteria revealed that the two type-III secretion systems that this pathogen has are temporally regulated in a strictly defined manner inside the fibroblast. Loss of this temporal control results in bacteria that either proliferate or are killed by the host cell. These data highlight how infection may proceed only when factors are put into game in a coordinated fashion by intracellular bacteria at precise times upon colonization of the host cell. William Sullivan (University of California, Santa Cruz) reported interesting aspects of the biology of Wolbachia, an insect and nematode endosymbiont that is inherited via the germ line (oocytes). Wolbachia is transmitted through invertebrates and causes important human diseases such as African River Blindness and Elephantiasis. Using Drosophila as a model, W. Sullivan showed that this bacterium during oogenesis utilizes the host microtubule network and the respective motors to first move to the anterior side of oocytes in a dyneindependent manner and later to the posterior side using kinesin. Host factors such as Gurken (Grk) are required for Wolbachia proliferation. Both the mRNA and protein forms of this host factor influences Wolbachia titers. The Grk protein acts as a transforming growth factor homolog whereas grk mRNA serves as a platform to assemble a protein complex controlling dorsal/ventral determination in Drosophila. Interestingly, Wolbachia colocalizes with grkRNP complexes. Wolbachia and the host could establish a tight regulatory loop modulated by grkRNP function and the extent at which bacterial proliferate. This was a clear example of how intracellular bacterial pathogens and hosts can reach 'balanced' stages ensuring homeostasis in both partners. Pascale Cossart (Institut Pasteur, Paris) described the key role played by mitochondria in Listeria infection. This organelle 'fragments' upon bacterial infection in a process dependent on listeriolysin-O (LLO) and the uptake of extracellular Ca 2þ (Fig 1) (Fig 1) . This phenomenon, which is starting to be analysed at the genetic and molecular level, has a tremendous impact in the fate of intracellular infections. Experiments performed in microfluidic devices coupled to time-lapse fluorescence microscopy revealed that M. tuberculosis populations are composed of individuals growing at different doubling rates, ranging from 6-7 h to 2-3 weeks. Some individuals of the population persist in the presence of the antibiotic and daughter cells derived by outgrowth of the survivors after antibiotic withdrawal show the same kinetics of cell death upon re-exposure to the antibiotic.
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Francisco Moreover, the bacteria proliferating within the macrophages of these structures express several drug-efflux pumps that both enable their intracellular growth and induce antibiotic tolerance. Tumour necrosis factor (TNF) was confirmed to be a key defence molecule against mycobacteria and a new primary mechanism uncovered in the zebrafish for its protection. Genetic data first in the zebrafish and then in human populations showed that production of LTA4H, an enzyme involved in arachidonic acid metabolism, correlates to host susceptibility to intracellular infections by this pathogen. LTA4H production is tightly linked to synthesis of lipoxins A4 and leukotriene B4, which modulate TNF levels. High lipoxin A4 levels leads to low TNF production and increased bacterial growth and the reverse occurs for leukotriene B4. Importantly, the data accumulated reinforce the old assumption that a 'balanced' host response to M. tuberculosis is fundamental to control infection. Thus, human individuals having either low or high LTA-4H levels are equally susceptible to infections caused by this intracellular pathogen. This evidence alerts us to a scenario in which treatment with anti-inflammatory drugs on infected human individuals can in one group control the infection whereas in the other exacerbates the disease.
In conclusion, the Workshop unravelled great challenges for future research in the biology of these successful intracellular pathogens, especially in areas still under-investigated as population dynamics during the infection process from both the pathogen and host sides. Such variability is convincing the researchers in this field to consider disease, asymptomatic infection or pathogen clearance as different manifestations of a same game, in which a few players may dictate the most important rules. The understanding of these differential behaviours at a mechanistic level signifies a tremendous amount of work, which will be certainly rewarding considering that resulting information will help to prevent or treat the important diseases that intracellular bacterial pathogens cause in humans.
